Six patients in Kazakhstan taking part in testing of a cancer treatment drug developed by local scientists have experienced a slowdown in tumor growth, and one had the tumor shrink. Vice-President of the Kazakh National Academy of Sciences Dos Sarbassov revealed the results of the initial phases of the drug trial.
«After the first drug intake, the conditions of 15 cancer patients stabilized, and the tumors of six of them stopped growing. Currently, the patients are receiving an increased dose of the drug, as health specialists have confirmed the absence of toxicity,» Sarbassov explained.